Chapter 28: Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries.
Matti Lehtinen;
Rolando Herrero;
Philippe Mayaud
;
Ruanne Barnabas;
Joakim Dillner;
Jorma Paavonen;
Peter G Smith
;
(2006)
Chapter 28: Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries.
Vaccine, 24 Sup (SUPPL.).
S3/233-S3/241.
ISSN 0264-410X
DOI: 10.1016/j.vaccine.2006.05.109
We review studies of the implementation of human papillomavirus (HPV) vaccination programmes in developed and developing countries. The review spans the period from establishment of long-term vaccine efficacy follow-up studies, operational research on issues of vaccine preparedness, and relevant predictive modelling studies during the pre-licensure phase to plans of phase IV effectiveness trials, forms of epidemiological surveillance, and further operational research in the post-licensure phase. Much of the research is already ongoing. Depending on the results of the planned immuno bridging studies among HIV-negative and HIV-positive women, further phase III and/or phase IV trials may be warranted.
ORCID: https://orcid.org/0000-0001-5730-947X
ORCID: https://orcid.org/0000-0003-0080-7560